Four Novartis medicines for cancer, asthma, high blood pressure and wet AMD approved in Japan
Tasigna, Xolair, Co-Dio and Lucentis provide novel and effective treatment options for serious diseases
23-Jan-2009 -
Four Novartis medicines were approved in Japan - Tasigna® for the treatment of a life-threatening form of leukemia, Xolair® for severe asthma, Co-Dio®] for high blood pressure, and Lucentis® for wet age-related macular degeneration (AMD).
Tasigna (nilotinib) is approved in Japan for the ...
allergic diseases
asthma
chronic myeloid leukemia
+12